Roles of TLR7 in Activation of NF-κB Signaling of Keratinocytes by Imiquimod

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Li, Zheng Jun ^a   Sohn, Kyung Cheol ^a   Choi, Dae Kyoung ^a   Shi, Ge ^b   Hong, Dongkyun ^a   Lee, Han Eul ^c   Whang, Kyu Uang ^c   Lee, Young Ho ^a   Im, Myung ^a   Lee, Young ^a   Seo, Young Joon ^a   Kim, Changok Deok ^a   Lee, Jeung Hoon ^a  

^a Chungnam National University   (South Korea)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c Soonchunhyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; IMIQUIMOD; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MICRORNA; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN RNA BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

AMINOQUINOLINES; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; KERATINOCYTES; NF-KAPPA B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 7; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885410480     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077159     Document Type: Article

References (31)

1. Medzhitov R, (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145.
2. Iwasaki A, Medzhitov R, (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
3. Trinchieri G, Sher A, (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7: 179-190.
4. McInturff JE, Modlin RL, Kim J, (2005) The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 125: 1-8.
5. Becker CE, O'Neill LA, (2007) Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin Immunopathol 29: 239-248.
6. Deane JA, Bolland S, (2006) Nucleic acid-sensing TLRs as modifiers of autoimmunity. J Immunol 177: 6573-6578.
7. Kawasaki T, Kawai T, Akira S, (2011) Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol Rev 243: 61-73.
8. Marek LR, Kagan JC, (2011) Deciphering the function of nucleic acid sensing TLRs one regulatory step at a time. Front Biosci 16: 2060-2068.
9. Janeway CA Jr, Medzhitov R, (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216.
10. Miller LS, Modlin RL, (2007) Toll-like receptors in the skin. Semin Immunopathol 29: 15-26.
11. Schon MP, Schon M, Klotz KN, (2006) The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. J Invest Dermatol 126: 1338-1347.
12. Lee Y, Kim H, Kim S, Kim KH, Chung JH, (2010) Activation of toll-like receptors 2, 3 or 5 induces matrix metalloproteinase-1 and-9 expression with the involvement of MAPKs and NF-κB in human epidermal keratinocytes. Exp Dermatol 19: e44-e49.
13. Bong AB, Bonnekoh B, Franke I, Schön M, Ulrich J, et al. (2002) Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology 205: 135-138.
14. Geisse JK, Rich P, Pandya A, Gross K, Andres K, et al. (2002) Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 47: 390-398.
15. Stary G, Bangert C, Tauber M, Strohal R, Kopp T, et al. (2007) Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J Exp Med 204: 1441-1451.
16. Kollisch G, Kalali BN, Voelcker V, Wallich R, Behrendt H, et al. (2005) Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 114: 531-541.
17. Lebre MC, van der Aar AM, van Baarsen L, van Capel TM, Schuitemaker JH, et al. (2007) Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol 127: 331-341.
18. Pivarcsi A, Bodai L, Rethi B, Kenderessy-Szabó A, Koreck A, et al. (2003) Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 15: 721-730.
19. Seo EY, Namkung JH, Lee KM, Lee WH, Im M, et al. (2005) Analysis of calcium-inducible genes in keratinocytes using suppression subtractive hybridization and cDNA microarray. Genomics 86: 528-538.
20. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, et al. (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3: 196-200.
21. Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, et al. (2002) Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 3: 499.
22. Kono T, Kondo S, Pastore S, Shivji GM, Tomai MA, et al. (1994) Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression. Lymphokine Cytokine Res 13: 71-76.
23. Fujisawa H, Shivji GM, Kondo S, Wang B, Tomai MA, et al. (1996) Effect of a novel topical immunomodulator, S-28463, on keratinocyte cytokine gene expression and production. J Interferon Cytokine Res 16: 555-559.
24. Morizane S, Yamasaki K, Mühleisen B, Kotol PF, Murakami M, et al. (2012) Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J Invest Dermatol 132: 135-143.
25. Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, et al. (2009) Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 206: 1983-1994.
26. Mohty M, Vialle-Castellano A, Nunes JA, Isnardon D, Olive D, et al. (2003) IFN-α skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. J Immunol 171: 3385-3393.
27. Wu JK, Siller G, Strutton G, (2004) Psoriasis induced by topical imiquimod. Australas J Dermatol 45: 47-50.
28. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182: 5836-5845.
29. Lowes MA, Bowcock AM, Krueger JG, (2007) Pathogenesis and therapy of psoriasis. Nature 445: 866-73.
30. De Pita O, Nardis C, Lupi F, Luci CA, Frezzolini A, et al. (2011) Modulation of Toll-like receptors in psoriatic patients during therapy with adalimumab. Int J Immunopathol Pharmacol 24: 185-188.
31. Shi G, Sohn KC, Li Z, Choi DK, Park YM, et al. (2013) Expression and functional role of sox9 in human epidermal keratinocytes. PLoS One 8: e54355.